PEPFAR has saved more than 25 million lives since its inception. It has strengthened health systems and helped stabilize communities globally. This valuable program promotes maternal and child health, ...

New data demonstrated that long-acting cabotegravir was preferable to daily dolutegravir/lamivudine in treatment-naive people living with HIV.

Previous treatment for depression, high BMI and inflammation levels, and early signs of functional impairment may be risk factors for physical function decline in HIV.

The FDA has accepted the New Drug Application for doravirine/islatravir for adults with virologically-suppressed HIV-1 infection.

The deal would shield PEPFAR from the Trump Administration’s plan to cancel billions in previously approved but unspent ...

Republicans in the US Senate have said they will spare the US-backed HIV/Aids programme Pepfar from cuts, amid a larger ...

A separate analysis of the real-world trial found that those who switched from daily antiretroviral treatment to Cabenuva had fewer concerns about treatment.

US funding cuts to global HIV prevention programs are estimated to cause 4 million deaths and 6 million cases of HIV.

The Senate could vote as soon as Wednesday on a so-called rescissions package, significantly impacting public media funding ...

At Essence Festival’s Global Black Economic Forum, Braxton joined Dr. Contessa and Raheem DeVaughn to speak candidly about HIV prevention, breast health, and taking control of your body.

Study links lower income and education levels to reduced cancer treatment access for people living with HIV in the US, ...

This story was originally published by The Institute for Public Service Reporting Memphis. Healthcare providers across ...